MCID: CRB026
MIFTS: 34

Cerebellar Astrocytoma

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Cerebellar Astrocytoma

MalaCards integrated aliases for Cerebellar Astrocytoma:

Name: Cerebellar Astrocytoma 12 15 74
Astrocytoma of Cerebellum 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4848
NCIt 51 C9475
UMLS 74 C0740480

Summaries for Cerebellar Astrocytoma

MalaCards based summary : Cerebellar Astrocytoma, also known as astrocytoma of cerebellum, is related to pilocytic astrocytoma of cerebellum and pilocytic astrocytoma. An important gene associated with Cerebellar Astrocytoma is SERPINA3 (Serpin Family A Member 3), and among its related pathways/superpathways is Oncogenic MAPK signaling. The drugs Vincristine and Ifosfamide have been mentioned in the context of this disorder. Affiliated tissues include brain, cerebellum and bone, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Related Diseases for Cerebellar Astrocytoma

Graphical network of the top 20 diseases related to Cerebellar Astrocytoma:



Diseases related to Cerebellar Astrocytoma

Symptoms & Phenotypes for Cerebellar Astrocytoma

GenomeRNAi Phenotypes related to Cerebellar Astrocytoma according to GeneCards Suite gene sharing:

27 (show all 13)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-121 9.47 MARK3
2 Increased shRNA abundance (Z-score > 2) GR00366-A-127 9.47 IDH1
3 Increased shRNA abundance (Z-score > 2) GR00366-A-136 9.47 IDH1
4 Increased shRNA abundance (Z-score > 2) GR00366-A-138 9.47 IDH1
5 Increased shRNA abundance (Z-score > 2) GR00366-A-147 9.47 IDH1
6 Increased shRNA abundance (Z-score > 2) GR00366-A-172 9.47 IDH1 MARK3
7 Increased shRNA abundance (Z-score > 2) GR00366-A-185 9.47 MARK3
8 Increased shRNA abundance (Z-score > 2) GR00366-A-190 9.47 MARK3
9 Increased shRNA abundance (Z-score > 2) GR00366-A-21 9.47 MARK3
10 Increased shRNA abundance (Z-score > 2) GR00366-A-39 9.47 IDH1
11 Increased shRNA abundance (Z-score > 2) GR00366-A-47 9.47 IDH1
12 Increased shRNA abundance (Z-score > 2) GR00366-A-67 9.47 MARK3
13 Increased shRNA abundance (Z-score > 2) GR00366-A-85 9.47 MARK3

Drugs & Therapeutics for Cerebellar Astrocytoma

Drugs for Cerebellar Astrocytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 206)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1,Not Applicable 2068-78-2, 57-22-7 5978
2
Ifosfamide Approved Phase 3,Phase 1,Phase 2 3778-73-2 3690
3
Methotrexate Approved Phase 3,Phase 2 1959-05-2, 59-05-2 126941
4
Prednisone Approved, Vet_approved Phase 3,Phase 2 53-03-2 5865
5
Lomustine Approved, Investigational Phase 3,Phase 1 13010-47-4 3950
6
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 441203 84093 2767
7
Etoposide Approved Phase 3,Phase 1,Phase 2,Not Applicable 33419-42-0 36462
8
Mechlorethamine Approved, Investigational Phase 3,Phase 2,Phase 1 51-75-2 4033
9
Levoleucovorin Approved, Investigational Phase 3,Phase 2 68538-85-2
10
leucovorin Approved Phase 3,Phase 2 58-05-9 6006 143
11
Carboplatin Approved Phase 3,Phase 2,Phase 1,Not Applicable 41575-94-4 38904 10339178 498142
12
Lenograstim Approved, Investigational Phase 3,Phase 1,Phase 2 135968-09-1
13
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 6055-19-2, 50-18-0 2907
14
Temozolomide Approved, Investigational Phase 3,Phase 2,Phase 1,Not Applicable 85622-93-1 5394
15
Thiotepa Approved, Investigational Phase 3,Phase 2,Phase 1 52-24-4 5453
16
Sargramostim Approved, Investigational Phase 3,Phase 2,Phase 1 123774-72-1, 83869-56-1
17
Isotretinoin Approved Phase 3 4759-48-2 5538 5282379
18
Thioguanine Approved Phase 3 154-42-7 2723601
19
Procarbazine Approved, Investigational Phase 3,Phase 2,Phase 1 671-16-9 4915
20
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 1177-87-3
21
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
22
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
23
Ondansetron Approved Phase 3 99614-02-5 4595
24
Cyproheptadine Approved Phase 3,Phase 2 129-03-3 2913
25
Histamine Approved, Investigational Phase 3,Phase 2 51-45-6 774
26
Calcium Approved, Nutraceutical Phase 3,Phase 2 7440-70-2 271
27
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2,Phase 1 59-30-3 6037
28
Tretinoin Approved, Investigational, Nutraceutical Phase 3 302-79-4 5538 444795
29
Isophosphamide mustard Phase 3,Phase 1,Phase 2 0
30 Anti-Inflammatory Agents Phase 3,Phase 2,Phase 1
31 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1,Not Applicable
32 Antimetabolites Phase 3,Phase 2,Phase 1
33 Etoposide phosphate Phase 3,Phase 1,Phase 2,Not Applicable
34 Hormones Phase 3,Phase 2,Phase 1
35 Vitamin B Complex Phase 3,Phase 2,Phase 1
36 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
37 Antimetabolites, Antineoplastic Phase 3,Phase 2,Phase 1
38 Antineoplastic Agents, Hormonal Phase 3,Phase 2,Phase 1,Not Applicable
39 Hormone Antagonists Phase 3,Phase 2,Phase 1
40 Immunologic Factors Phase 3,Phase 2,Phase 1,Not Applicable
41 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
42 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1,Not Applicable
43 Alkylating Agents Phase 3,Phase 2,Phase 1,Not Applicable
44 Antimitotic Agents Phase 3,Phase 2,Phase 1,Not Applicable
45 Vitamin B9 Phase 3,Phase 2,Phase 1
46 Calcium, Dietary Phase 3,Phase 2
47 Folate Phase 3,Phase 2,Phase 1
48 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1,Not Applicable
49 Dermatologic Agents Phase 3,Phase 2,Phase 1
50 Antirheumatic Agents Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 101)
# Name Status NCT ID Phase Drugs
1 Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas Unknown status NCT00278278 Phase 3 cisplatin;etoposide;ifosfamide;lomustine;methotrexate;prednisone;vincristine sulfate
2 Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma Unknown status NCT00003015 Phase 3 carboplatin;vincristine sulfate
3 Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors Unknown status NCT00392886 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide;methotrexate;temozolomide;thiotepa;vincristine sulfate
4 High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas Completed NCT00078988 Phase 3 carboplatin;etoposide;isotretinoin;thiotepa
5 Combination Chemotherapy in Treating Children With Progressive Brain Tumors Completed NCT00002944 Phase 3 carboplatin;lomustine;procarbazine hydrochloride;thioguanine;vincristine sulfate
6 Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Completed NCT01346267 Phase 3
7 Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
8 Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors Unknown status NCT00313521 Phase 2 thiotepa
9 Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma Unknown status NCT00005084 Phase 2
10 Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma Unknown status NCT00360945 Phase 2 cisplatin;temozolomide
11 Radiation Therapy in Treating Young Patients With Gliomas Unknown status NCT00238264 Phase 2
12 Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors Unknown status NCT00281905 Phase 2 carboplatin;cisplatin;cyclophosphamide;methotrexate;vincristine sulfate
13 Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor Completed NCT00004068 Phase 2 irinotecan hydrochloride;temozolomide
14 Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy Completed NCT00679354 Phase 2 cilengitide
15 Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma Completed NCT01462695 Phase 2 Sunitinib Malate
16 Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma Completed NCT00070525 Phase 2 tipifarnib
17 Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment Completed NCT00091182 Phase 2 oxaliplatin
18 Irinotecan in Treating Children With Refractory Solid Tumors Completed NCT00004078 Phase 2 irinotecan hydrochloride
19 Carboplatin in Patients With Progressive Gliomas Completed NCT00002749 Phase 2 carboplatin
20 Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors Completed NCT00002463 Phase 2 MOPP Regimen;Leucovorin Calcium;Mechlorethamine Hydrochloride;Methotrexate;Prednisone;Procarbazine Hydrochloride;Vincristine Sulfate
21 Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment Completed NCT00066248 Phase 2 cyproheptadine hydrochloride;megestrol acetate
22 Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors Completed NCT00005952 Phase 1, Phase 2 temozolomide
23 Lobradimil and Carboplatin in Treating Children With Brain Tumors Completed NCT00019422 Phase 2 carboplatin;lobradimil
24 Vinorelbine in Treating Children With Recurrent or Refractory Cancers Completed NCT00003234 Phase 2 vinorelbine tartrate
25 Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors Completed NCT00003241 Phase 2 phenylacetate
26 Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma Completed NCT00124657 Phase 1, Phase 2 Erlotinib hydrochloride
27 Docetaxel in Treating Children With Recurrent Solid Tumors Completed NCT00002825 Phase 2 docetaxel
28 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers Completed NCT00002752 Phase 1, Phase 2
29 Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma Completed NCT00008008 Phase 2 cyclophosphamide;thiotepa
30 Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma Completed NCT00006102 Phase 2 becatecarin
31 Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors Completed NCT00005955 Phase 2 temozolomide
32 Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors Completed NCT00002608 Phase 2 cisplatin;doxorubicin hydrochloride;tamoxifen citrate
33 Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer Active, not recruiting NCT00445965 Phase 2
34 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Active, not recruiting NCT00788125 Phase 1, Phase 2 carboplatin;dasatinib;etoposide phosphate;ifosfamide
35 Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma Unknown status NCT00360854 Phase 1 erlotinib hydrochloride
36 Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors Unknown status NCT00002647 Phase 1 verteporfin
37 Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma Completed NCT00357253 Phase 1 capecitabine
38 Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Completed NCT01076530 Phase 1 vorinostat;temozolomide
39 ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors Completed NCT00946335 Phase 1 veliparib;temozolomide
40 Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors Completed NCT00100880 Phase 1 lenalidomide
41 Cilengitide in Treating Children With Refractory Primary Brain Tumors Completed NCT00063973 Phase 1 cilengitide
42 Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors Completed NCT00052780 Phase 1 O6-benzylguanine;temozolomide
43 Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas Completed NCT00012181 Phase 1 alvocidib
44 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Completed NCT00019630 Phase 1 doxorubicin HCl liposome
45 Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors Completed NCT00077454 Phase 1 erlotinib hydrochloride;temozolomide
46 Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Completed NCT00994500 Phase 1 vorinostat;bortezomib
47 Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma Completed NCT00363272 Phase 1 ispinesib
48 AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors Completed NCT00326664 Phase 1 Cediranib Maleate
49 Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas Completed NCT00101270 Phase 1 irinotecan hydrochloride;oxaliplatin
50 FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Completed NCT00053963 Phase 1 romidepsin

Search NIH Clinical Center for Cerebellar Astrocytoma

Genetic Tests for Cerebellar Astrocytoma

Anatomical Context for Cerebellar Astrocytoma

MalaCards organs/tissues related to Cerebellar Astrocytoma:

42
Brain, Cerebellum, Bone, Spinal Cord, Bone Marrow, Liver, T Cells

Publications for Cerebellar Astrocytoma

Articles related to Cerebellar Astrocytoma:

(show top 50) (show all 98)
# Title Authors Year
1
Treatment of corneal neovascularization with topical aflibercept in a case of exposure keratopathy following cerebellar astrocytoma surgery. ( 30574927 )
2019
2
Giant congenital melanocytic nevus associated with cerebellar astrocytoma. ( 29619995 )
2018
3
Post-operative accidental diagnosis of intra-cerebellar astrocytoma in an emergency appendicectomy case. ( 26962259 )
2016
4
Pediatric cerebellar astrocytoma: a review. ( 26351221 )
2015
5
Cerebellar astrocytoma presenting with headache and nystagmus in a 20-year-old male. ( 24485699 )
2014
6
Neurosurgical treatment of low-grade cerebellar astrocytoma in children and adolescents: a single consecutive institutional series of 100 patients. ( 23240848 )
2013
7
Simultaneous conus medullaris ependymoma and cerebellar astrocytoma in the same patient. ( 19537133 )
2009
8
Postoperative surveillance magnetic resonance imaging for cerebellar astrocytoma. ( 19960748 )
2009
9
Outcome of children with low-grade cerebellar astrocytoma: long-term complications and quality of life. ( 18690461 )
2008
10
Differential prefrontal-like deficit in children after cerebellar astrocytoma and medulloblastoma tumor. ( 18412947 )
2008
11
Cerebellar astrocytoma presenting with precocious puberty in a girl. Case report. ( 17644924 )
2007
12
Hemifacial spasm as the initial manifestation of childhood cerebellar astrocytoma. ( 17070492 )
2006
13
Spontaneous regression of cerebellar astrocytoma after subtotal resection. ( 16552566 )
2006
14
Epilepsy and neuropsychologic deficit in a child with cerebellar astrocytoma. ( 16970895 )
2006
15
Long-term effects of transient cerebellar mutism after cerebellar astrocytoma or medulloblastoma tumor resection in childhood. ( 16155765 )
2006
16
Long-term sequelae in children after cerebellar astrocytoma surgery. ( 15111667 )
2004
17
Difficulties in the diagnosis of cerebellar astrocytoma-induced deafness in infancy: a case report. ( 15100653 )
2004
18
Taurine detection by proton magnetic resonance spectroscopy in medulloblastoma: contribution to noninvasive differential diagnosis with cerebellar astrocytoma. ( 15458590 )
2004
19
Sub-classification of low-grade cerebellar astrocytoma: is it clinically meaningful? ( 14631523 )
2003
20
Unilateral deafness with persistent otoacoustic emissions after neurosurgical removal of a cerebellar astrocytoma. ( 11226965 )
2001
21
Evolution of malignant cerebellar astrocytoma at the site of a treated medulloblastoma: report of two cases. ( 11534690 )
2001
22
Hypernasality--a rare initial symptom of a cerebellar astrocytoma. ( 11035179 )
2000
23
Contralateral cortical diaschisis in a patient with cerebellar astrocytoma after radiation therapy. ( 10836690 )
2000
24
Human herpesvirus-6 associated encephalitis with subsequent infantile spasms and cerebellar astrocytoma. ( 10875530 )
2000
25
Cerebellar astrocytoma in an adult with extensive leptomeningeal spread. ( 11045208 )
2000
26
Cerebellar astrocytoma associated with von Hippel-Lindau disease: case report with molecular findings. ( 10627785 )
1999
27
Cerebellar astrocytoma presenting with acute esotropia in a 5 year-old girl. Case report. ( 11456255 )
1999
28
[Development of cerebellar astrocytoma in a patient with acute myeloid leukemia 8 years after his second bone marrow transplant]. ( 10390894 )
1999
29
Cerebellar astrocytoma and Asperger syndrome. ( 10461572 )
1999
30
Predicting disease progression in childhood cerebellar astrocytoma. ( 9840364 )
1998
31
Intraventricular and leptomeningeal dissemination of a pilocytic cerebellar astrocytoma in a child with a ventriculoperitoneal shunt: case report. ( 11013652 )
1998
32
Palatal myoclonus induced by extirpation of a cerebellar astrocytoma. Case report. ( 9609309 )
1998
33
Malignant cerebellar astrocytoma developing 15 years after radiation therapy for a medulloblastoma. ( 9637208 )
1998
34
Cerebellar astrocytoma: experience with 54 cases surgically treated at the Mayo Clinic, Rochester, Minnesota, from 1978 to 1990. ( 9254090 )
1997
35
Rapidly growing calcified cerebellar astrocytoma in infants. ( 8674077 )
1996
36
Cerebellar astrocytoma manifesting as isolated, comitant esotropia in childhood. ( 8610811 )
1996
37
Cerebellar astrocytoma: report of 13 cases aged over 20 years and review of the literature. ( 8864501 )
1996
38
Radiology rounds. Cerebellar astrocytoma. ( 7580377 )
1995
39
Cerebellar astrocytoma of childhood: long-term follow-up. ( 7758018 )
1995
40
Benign cerebellar astrocytoma in childhood: experience at the Hospital for Sick Children 1980-1992. ( 7842424 )
1994
41
Bilateral fluctuating trochlear nerve palsy secondary to cerebellar astrocytoma. ( 8180876 )
1994
42
Cerebellar astrocytoma with extensive lipidization mimicking adipose tissue. ( 7847080 )
1994
43
Ring chromosome 12 resulting from nonrandom telomeric associations with the short arm of chromosome 15 in a cerebellar astrocytoma. ( 7504519 )
1993
44
Pilocytic cerebellar astrocytoma in adults: case report. ( 8493594 )
1993
45
Prolonged I-III interwave interval in cerebellar astrocytoma. ( 8369545 )
1993
46
Results of post-operative or exclusive radiotherapy in grade I and grade II cerebellar astrocytoma patients. ( 1609128 )
1992
47
Cerebellar astrocytoma with repeated episodes of fourth ventricle isolation causing peritoneal shunt tube obstruction--case report. ( 1381063 )
1992
48
"One-and-a-half" syndrome after a resection of a midline cerebellar astrocytoma: case report and discussion of the literature. ( 1961411 )
1991
49
Bilateral symmetrical striopallidodentate calcification associated with pseudohypoparathyroidism demonstrated in a patient with cerebellar astrocytoma. ( 2034361 )
1991
50
Benign recurrence of a pilocytic cerebellar astrocytoma 36 years after radical removal: case report. ( 2034360 )
1991

Variations for Cerebellar Astrocytoma

Expression for Cerebellar Astrocytoma

Search GEO for disease gene expression data for Cerebellar Astrocytoma.

Pathways for Cerebellar Astrocytoma

Pathways related to Cerebellar Astrocytoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
10.76 KIAA1549 MARK3

GO Terms for Cerebellar Astrocytoma

Cellular components related to Cerebellar Astrocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 secretory granule lumen GO:0034774 8.62 IDH1 SERPINA3

Biological processes related to Cerebellar Astrocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 response to oxidative stress GO:0006979 8.62 IDH1 PNKP

Sources for Cerebellar Astrocytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....